Type in a keyword and see the report right away. Explore your online world!
If you have already a Newsmeter account:
You can free sign up for Newsmeter:
x
Sentry Investment Management LLC decreased its position in shares of ResMed Inc. ( NYSE: RMD – Free Report ) by 17. 1% during the 2nd quarter, according to the company in its most recent 13F filing wi...
09.12.2024 Dakotafinancialnews.com and 120 sites
Welcome to my ChartWatch Daily ASX Scans series. Here I present scan lists based on my trend following technical analysis methodology. My goal is to alert you to the best uptrends and downtrends on th...
09.09.2024 Tradingview.com and 2 sites
The S&P/ASX 200 closed 25. 3 points lower, down 0. 32%. 'It could have been worse' is the takeaway from today's trade on the Australian share market, certainly, given leads from overseas stocks and co...
09.09.2024 Tradingview.com and 1 sites
ASX 200 futures are trading 78 points higher, up 0. 97%, as of 8: 30 am AEST. Major US benchmarks bounced from their worst week of the year, the market is unsure whether or not the Fed will cut 25 or ...
09.09.2024 Tradingview.com and 1 sites
ResMed Inc. ( NYSE: RMD – Get Free Report ) CEO Michael J. Farrell sold 14, 683 shares of the firm’s stock in a transaction that occurred on Monday, September 9th. The stock was sold at an average price of $248. 38, for a total transaction of $3, 646, 963. 54. Following the sale, the chief executive officer now directly owns 464, 169 shares in the company, valued at approximately $115, 290, 296. 22. The sale was disclosed in a document filed with the SEC, which is available through the SEC websi...
09.10.2024 Dakotafinancialnews.com and 24 sites
Welcome back to the 52-week Series– A recap of ASX 200 stocks that have tagged a fresh yearly highs and lows in the past week. 52-Week Highs and Lows by Sector Financials: 9 Highs, 1 Low Real Estate: ...
09.10.2024 Tradingview.com
Reporter Name Relationship Type Amount SEC Filing Farrell Michael J. Chief Executive Officer Sell $3, 646, 950 Form 4 Sandercock Brett Chief Financial Officer Sell $246, 420 Form 4 ResMed's Chief Exec...
09.11.2024 Tradingview.com
Defensive healthcare stocks and companies that delivered better-than-expected results during reporting season have managed to buck the trend, not only withstanding the recent selloff but also climbing...
09.10.2024 Tradingview.com
** Brokerage KeyBanc Capital Markets says it views the news of Apple AAPL launching sleep apnea detection in its new Watch Series 10, and existing Watch Series 9 and Watch Ultra 2 as positive for medi...
09.10.2024 Tradingview.com
𝐀𝐧𝐭𝐢𝐜𝐢𝐩𝐚𝐭𝐞𝐝 𝐆𝐫𝐨𝐰𝐭𝐡 𝐢𝐧 𝐈𝐧𝐜𝐨𝐦𝐞: The size of the global sleep technology devices market was estimated at USD 17. 12 billion in 2023, and from 2024 to 2030, the market's total revenue is projected to increase at a CAGR of 14. 90%...
09.11.2024 Openpr.com and 32 sites
